Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single-blind, placebo-controlled study of BPL-003 in healthy volunteers for assessing the effects of 5-MeO-DMT in the human brain

Next Previous
Trial Profile

A single-blind, placebo-controlled study of BPL-003 in healthy volunteers for assessing the effects of 5-MeO-DMT in the human brain

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 12 Jun 2024 New trial record
  • 03 Jun 2024 According to a Beckley Canopy Therapeutics media release, Initial results from the study are expected in 2026.
  • 03 Jun 2024 According to a Beckley Canopy Therapeutics media release, this research is being overseen by Dr. Christopher Timmermann and Dr David Erritzoe, and is being led by PhD student Tommaso Barba at Imperial College London.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top